Q2 2019 G1 Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen, and welcome to the G1 Therapeutics Second Quarter Corporate and Financial Updates. (Operator Instructions) As a reminder, this conference call may be recorded. I would now like to turn the call -- conference over to your host, Mr. Jeff Macdonald, Head of Investor Relations. Sir, please go ahead.
Thank you, operator. Good afternoon, everyone, and welcome to the G1 Therapeutics Second Quarter 2019 Update.
Joining me are Mark Velleca, Chief Executive Officer; Raj Malik, Chief Medical Officer and Senior Vice President, R&D; and Jen Moses, Chief Financial Officer.
Before we begin, I would like to remind you that today's call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and involve risks and uncertainties that could cause actual results to differ materially from expected results. Please refer to our filings with the SEC, which are available
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
